Treatment for MERS-CoV? {#cesec10}
=======================

Since its emergence in September 2012, about half of the individuals known to be infected with Middle East respiratory syndrome coronavirus (MERS-CoV) have died. There is currently no treatment for MERS-CoV infection but interferon alfa-2b and ribavirin reduce viral replication in vitro. Now, researchers report that early treatment with this combination of drugs, which is already used clinically to treat other viral infections, reduces viral replication, moderates the host immune response, and [improves outcomes](http://dx.doi.org/10.1038/nm.3362){#interrefs10} in rhesus macaques infected with MERS-CoV, an animal model for mild-to-moderate MERS-CoV infection.

Viral diversity in mammals {#cesec20}
==========================

Most emerging infectious diseases are zoonoses that originate in wildlife and many are caused by viruses. But how many unknown (and potentially pathogenic) viruses are lurking in the undergrowth? By repeatedly sampling the Indian flying fox (*Pteropus giganteus),* a mammalian wildlife host that is known to harbour emerging zoonotic pathogens, researchers have discovered and analysed the occurrence patterns of 55 viruses from nine viral families in this one species. Extrapolating from this [finding](http://dx.doi.org/10.1128/mBio.00598-13){#interrefs20}, the researchers estimate that there are at least 320 000 mammalian viruses awaiting discovery in these nine viral families.
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Resensitisation to antibiotics {#cesec30}
==============================

Resistance-modifying agents such as β-lactamase inhibitors restore the activity of β-lactam antibiotics against meticillin-resistant *Staphylococcus aureus* (MRSA) and other drug-resistant bacteria. To discover [resistance-modifying reagents](http://dx.doi.org/10.1073/pnas.1310459110){#interrefs30} with other modes of action, researchers have synthesised and screened 120 polycyclic indole alkaloids---indole alkaloids are structurally diverse natural products, often isolated from medicinal plants. Of1, a tricyclic indoline, potentiates the activity of β-lactams against several strains of MRSA but not against meticillin-sensitive *S aureus*, they report. Further development of Of1 could provide a new strategy for the treatment of antibiotic-resistant bacteria.

Parkin tuberculosis... {#cesec40}
======================

Intracellular bacteria are targeted to autophagosomes in eukaryotic cells through a ubiquitin-mediated pathway but which ligases conjugate ubiquitin to invading bacteria in this key innate defence mechanism? Intriguingly, genetic mutations in the regulatory region of *PARK2*---a gene that encodes the ubiquitin ligase [parkin](http://dx.doi.org/10.1038/nature12566){#interrefs40} and is often mutated in people with Parkinson\'s disease---increase human susceptibility to intracellular bacterial pathogens. A study now is involved in ubiquitin-mediated autophagy of *Mycobacterium tuberculosis*, highlighting an unexpected link between mitophagy (the elimination of damaged mitochondria) and infectious disease.

...and sequencing *M tuberculosis* {#cesec50}
==================================

Four whole-genome sequencing studies provide new information about the emergence of drug resistance in *M tuberculosis* and the evolution of this pathogen. By sequencing and analysing 161 isolates from China with a range of drug resistance profiles, [researchers](http://dx.doi.org/10.1038/ng.2735){#interrefs50} identify 121 new genes, intergenic regions, and single nucleotide polymorphisms that have strong, consistent associations with drug resistance. In a [second study](http://dx.doi.org/10.1038/ng.2747){#interrefs60}, researchers analysed the genomes of 123 *M tuberculosis* strains and identify genes that are under positive selection in drug-resistant isolates, including all of a set of known resistance markers and an additional 39 genes and intergenic regions. In a [third study](http://dx.doi.org/10.1038/ng.2743){#interrefs70}, researchers investigate the evolution of drug resistance in *M tuberculosis* by characterising bacterial strains selected in vitro for ethambutol resistance and 63 clinical isolates. Ethambutol resistance, they report, is acquired through the acquisition of mutations that interact in complex ways. Finally, researchers [analyse](http://dx.doi.org/10.1038/ng.2744){#interrefs80} the genomes of 259 *M tuberculosis* complex strains to reconstruct the pathogen\'s evolutionary history. Their results show that *M tuberculosis* emerged about 70 000 years ago, accompanied anatomically modern people as they migrated out of Africa, and expanded with human populations during the Neolithic period.

Fungal hypervirulence {#cesec60}
=====================

A lineage of *Cryptococcus gattii*---a fungal pathogen that causes less than 1% of human cryptococcosis cases---that emerged in Canada and northwest America in 1999 is responsible for the largest recorded outbreak of a life-threatening fungal infection in a healthy population. To find out whether the hypervirulence traits associated with this outbreak could spread to other lineages through genetic reassortment and hybridisation, researchers have interbred different strains of the fungus. [Hypervirulence traits](http://www.plosgenetics.org/article/info%3Adoi%2F10.1371%2Fjournal.pgen.1003771){#interrefs90} present were readily transmitted between closely related strains, they report, but infrequently transmitted to distant strains.
